Search Results 801-810 of 12904 for immunosuppressant drugs

  1. Medical Research & Education - Mayo Clinic News Network

    ... medicine where the immune system plays a critical role. ... Mayo Clinic Q&A podcast: Study finds unique form of immunosuppression caused by brain cancer featured.

  2. Oncology (Medical) - Clinical trials - Mayo Clinic

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  3. Clinical trials - Oncology (Medical)

    This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides ...

  4. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, And Nivolumab In Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

    ... immunosuppressive drugs). Note: Replacement therapy (e.g., thyroxine ... History of allergies and adverse drug reaction to study drug components.

  5. Amikacin liposome (inhalation route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  6. Face Transplant Research Program - Transplant Research Center - Mayo Clinic Research

    The Face Transplant Research Program at Mayo Clinic studies facial reconstruction, reconstructive microsurgery, immunosuppression and long-term medical ...

  7. Inotuzumab ozogamicin (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Inebilizumab-cdon (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  9. Lung cancer drug offers a surprising new treatment against ovarian cancer - Mayo Clinic News Network

    Mayo Clinic study finds a lung cancer drug may enhance PARP inhibitors in ovarian cancer by blocking early drug resistance mechanisms.

  10. Stephanie M. Ferrell, M.D. - Doctors and Medical Staff - Mayo Clinic

    Drugs & Supplements · Healthy Lifestyle · Mayo Clinic ... Ferrell is a dual trained MD-PharmD with an extensive background in transplant-related immunosuppression ...